We subsequently extended this finding of PKM2 overexpression to high-grade muscle-invasive tumors in hybrid mice expressing activated HRAS and lacking p53, human cell lines representing low-and high-grade BCs and human BC specimens of both low- and high grades19. The gene discussed is PKM; the disease is breast cancer.